European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Revvity Gene Delivery GmbH, Gräfelfing, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Revvity Gene Delivery GmbH
SIRION BIOTECH GmbH
siRion GmbH

Identification

Ut
District Court of Munich HRB 161010
Sirul
Siren 841714751
Siret
Siret 84171475100010
EUID
DED2601V.HRB161010

Address

Am Haag 6, 82166 Gräfelfing, Germany
Planegg, Germany

Corporate purpose

21.10
Manufacture of basic pharmaceutical products

Development and distribution of biotechnological products, with the exception of activities subject to licensing, as well as all related and corporate purpose promoting transactions.

Financials

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Marketing & Tech

Network

Loading network
tax haven banner

Publications

25 Jun 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
30 Oct 2024
Managing Director: Volker H. O. Eckelt · No longer Managing Director: Christian Thirion
3 Jul 2024 as Sirion Biotech GmbH
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022
12 Jun 2024
No longer Managing Director: Alan Edward Fletcher
17 May 2024
Name: Revvity Gene Delivery GmbH · Company statute
14 May 2024 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
17 Jan 2024
Patent: Production of Viral Vectors
13 Dec 2023 as Sirion Biotech GmbH
Patent: AAV-Based Conditional Expression System
2 Oct 2023
Managing Director: Bryan Andrew Kipp
30 Aug 2023 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
29 Mar 2023 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Shareholding: 87 % 0,00 % © Richttafeln 2018 G von Klaus Heubeck Lizenz Heubeck-Richttafeln GmbH
17 Aug 2022
Patent: Therapeutic Papilloma Virus Vaccines
25 May 2022 via Creathor Venture Fund II GmbH & Co. KG also 04/12/2020, 22/01/2020, 09/01/2019
Shareholder: Creathor Venture Fund II GmbH & Co. KG
29 Apr 2022
Patent: AAV8 Capsid Variants with Enhanced Liver Targeting
11 Feb 2022 as SIRION BIOTECH GmbH
Address · Seat: Gräfelfing, Germany · Company statute
10 Feb 2022 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
7 Feb 2022 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
21 Jan 2022 via Sirion Biotech SAS
President: Sirion Biotech SAS
12 Jan 2022 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020
22 Dec 2021
Patent: Retroviral Transduction Using Poloxamers
26 Nov 2021 as SIRION BIOTECH GmbH
Managing Director: Alan Edward Fletcher, John Leo Healy
10 Nov 2021 as SIRION BIOTECH GmbH
No longer Managing Director: Dieter Lingelbach
10 Nov 2021 as Sirion Biotech GmbH
Patent: Means for Generating Adenoviral Vectors for Cloning Large Nucleic Acids
31 Aug 2021 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
18 Aug 2021
Patent: Therapeutic Papilloma Virus Vaccines
21 Jan 2021 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019
1 Dec 2020 as SIRION BIOTECH GmbH
Public funding (€149,895): Development and production of biological pacemaker adenovirus vectors, subproject: Development and production of adenovirus vectors for short-term biological pacemakers
28 Oct 2020
Patent: Retroviral Transduction Using Poloxamers
20 Jan 2020 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
13 Jan 2020 as Sirion Biotech GmbH
Wordmark: “LentiBOOST“
1 Jan 2020 as SIRION BIOTECH GmbH
Public funding (€99,948): Treatment of cancer through immunological intervention strategies targeting endogenous retroviral fossils in the human genome, subproject: Development of viral vectors for …
4 Dec 2019
Patent: Viral Transduction Using Poloxamines
16 Oct 2019
Patent: Pseudotyped Lentiviral Vectors
18 Jan 2019 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017
20 Aug 2018 as Sirion Biotech GmbH in France
Address · Legal form · Name: SIRION BIOTECH GMBH · Segment clas­si­fi­ca­tion
1 Jun 2018 as SIRION BIOTECH GmbH
Public funding (€198,373): Development of a therapeutic vaccine for the eradication of existing HPV infections, subproject: Design, generation, production and stability of adendovirus and MVA vectors
18 Apr 2018 as Sirion Biotech GmbH
Patent: Vaccine Against Beta-Herpesvirus Infection and USE Thereof
10 Jan 2018 as Sirion Biotech GmbH
Patent: Means and Methods to Increase Adenovirus Production
1 Oct 2017 as SIRION BIOTECH GmbH
Public funding (€410,217): Innovative diagnosis and development of novel therapeutics for viral diseases of the CNS, subproject: Development and validation of a new diagnostic method e.g …
14 Aug 2017 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016
19 Sept 2016 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015
28 Jan 2016 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014
1 Jan 2016 in Hor
EU funding (€454,500): Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes
30 Dec 2015 as SIRION BIOTECH GmbH
Capital: €237,728
29 Dec 2015 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
29 Dec 2015 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
18 Nov 2015 as SIRION BIOTECH GmbH
Capital: €234,268 · Share­holder agreement · Company statute
17 Nov 2015 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
5 Nov 2015 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
20 Jan 2015 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013
9 Jan 2015
Patent: Pseudotyped Lentiviral Vectors
1 Jan 2015 as Sirion Biotech GmbH
EU funding: Research Training Network on Integrated Component Cycling in Epithelial Cell Motility
25 Nov 2014 as SIRION BIOTECH GmbH
Capital: €212,258 · Company statute
24 Nov 2014 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
10 Nov 2014 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
1 Aug 2014 as SIRION BIOTECH GmbH
Public funding (€113,499): Peak cluster m4, Compound New therapeutics: identification of personalized tumor antigens in the form of endogenous retroviruses and evaluation of therapeutic potential by …
16 Jul 2014 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
6 Nov 2013 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012
3 Apr 2013 as SIRION BIOTECH GmbH
Capital: €187,286 · Company statute
8 Mar 2013 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
8 Mar 2013 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
28 Feb 2013
Patent: Retroviral Transduction Using Poloxamers
28 Feb 2013
Patent: Retroviral Transduction Using Poloxamers
29 Nov 2012 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
20 Nov 2012 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011
22 Oct 2012 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
22 Oct 2012 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
6 Jun 2012 as SIRION BIOTECH GmbH
Capital: €148,212 · Company statute
4 Jun 2012 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
4 Jun 2012 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
4 Apr 2012 as SIRION BIOTECH GmbH
Managing Director: Dieter Lingelbach · No longer Managing Director (1)
1 Oct 2011 in Fts
EU funding (€411,000): Development of Novel Treatment Strategies Based on Knowledge of Cellular Dysfunction in Diabetes
15 Jun 2011 as SIRION BIOTECH GmbH
Capital: €133,085 · Company statute
9 Jun 2011 as SIRION BIOTECH GmbH
Original document: “Liste der Gesellschafter“
30 May 2011 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
10 May 2011 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010
3 May 2011
Original document: “Liste der Gesellschafter“
30 Dec 2010 as SIRION BIOTECH GmbH
Patent: Nucleic Acid Molecules for Generating Adenoviral Vectors
22 Dec 2010 as SIRION BIOTECH GmbH
Capital: €117,958 · Company statute
14 Dec 2010
Original document: “Liste der Gesellschafter“
9 Dec 2010 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
12 Nov 2010
Original document: “Liste der Gesellschafter“
22 Oct 2010 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009
13 Oct 2010 as SIRION BIOTECH GmbH
Capital: €93,958 · Company statute
29 Sept 2010 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
28 Jul 2010 as SIRION BIOTECH GmbH
No longer Managing Director (1)
28 Oct 2009 as SIRION BIOTECH GmbH
Managing Director (1) · Capital: €93,959 · Company statute
30 Sept 2009 as SIRION BIOTECH GmbH
Original document: “Gesellschaftsvertrag / Satzung / Statut“
16 Sept 2009 as SIRION BIOTECH GmbH
No longer Managing Director (1)
15 Jul 2009 as SIRION BIOTECH GmbH
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008
13 Jul 2009 as SIRION GmbH
Wordmark: “SIRION“
1 Apr 2009 as SIRION BIOTECH GmbH
Name: SIRION BIOTECH GmbH · Company statute
10 Mar 2009
Original document: “Gesellschaftsvertrag / Satzung / Statut“
10 Dec 2008 as siRion GmbH
Capital: €72,900 · Company statute
11 Nov 2008 as siRion GmbH
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007
3 Nov 2008 as siRion GmbH
Capital: €48,900 · Company statute
29 Oct 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
27 Oct 2008
Original document: “Gesellschaftsvertrag / Satzung / Statut“
30 Jan 2008 as siRion GmbH
Managing Director (1)
10 Oct 2007 as siRion GmbH
Managing Director (2) · Capital: €45,300 · Seat: Planegg/Martinsried, Germany · Company statute
21 Jun 2007 as Sirion GmbH
Patent: Method for Freezing and Storing of Cells
20 Sept 2006 as siRion GmbH
Company statute · Development and distribution of biotechnological products, with the exception of activities subject to licensing, as well as all related and corporate purpose promoting transactions
15 Feb 2006 as siRion GmbH
Reg­is­tra­tion · Managing Director (2) · Capital: €25,000 · Share­holder agreement · Development and distribution of biotechnological products
There are no publications matching your search.

Mentions

5 Dec 2024 in Rne
Reg­is­tra­tion: 20/08/2018 · Segment clas­si­fi­ca­tion
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Revvity Gene Delivery GmbH, Gräfelfing, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.